Women, HIV, and HAART: Closing the gender gap

L. Hirschhorn*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


A greater susceptibility to the adverse effects of protease inhibitors is just one of many possible reasons highly active antiretroviral therapy has been less beneficial to women. Consider the obstacles and how you can help patients overcome them.

Original languageEnglish (US)
Pages (from-to)32-39
Number of pages8
JournalIM - Internal Medicine
Issue number1
StatePublished - Jan 1 1999

ASJC Scopus subject areas

  • Internal Medicine


Dive into the research topics of 'Women, HIV, and HAART: Closing the gender gap'. Together they form a unique fingerprint.

Cite this